← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.91 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.90 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89 Optimized Temporal Window for Metabolic Boosting Therapy Det (IFNG) — 0.89 TREM2-APOE Axis Dissociation for Selective DAM Activation (TREM2-APOE axis) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.88 APOE-Dependent Autophagy Restoration (MTOR) — 0.88 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.87 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.87 Complement Cascade Inhibition Synaptic Protection (%s) — 0.87 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.87 Optogenetic restoration of hippocampal gamma oscillations vi (PVALB) — 0.87 Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated (PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway) — 0.87 Glymphatic-Mediated Tau Clearance Dysfunction (MAPT) — 0.86 Closed-loop focused ultrasound targeting EC-II PV interneuro (PVALB) — 0.86 TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima (NAMPT) — 0.86 TREM2-Mediated Microglial Dysfunction Disrupts Perivascular (TREM2) — 0.86 Circadian Glymphatic Entrainment via Targeted Orexin Recepto (HCRTR1/HCRTR2) — 0.86 RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P (RBM45,GSK3B,TDP-43,TARDBP,hnRNP A1,HNRNPA1,phase separation,Liquid droplet) — 0.86
Add
|
× SNCA Oligomer Binding to × LAMP2A Liquid-Liquid Phas
LAMP2 · neurodegeneration · mechanistic
Composite 0.733
Price $0.50
Evidence For 0
Evidence Against 0
LAMP2A protein levels are regulated post-translationally by the AAA+ ATPase torsinA, which mediates extraction of aged or damaged LAMP2A from the lysosomal membrane for degradation. This torsinA-dependent turnover normally maintains a young pool of LAMP2A with high translocation competence. In PD, SNCA oligomers bind directly to the LAMP2A cytosolic domain (residues 1-24), physically blocking the torsinA recognition motif without affecting LAMP2A's ability to form SNCA complexes. This creates a
LAMP2 · neurodegeneration · mechanistic
Composite 0.783
Price $0.50
Evidence For 0
Evidence Against 0
LAMP2A exists in the lysosomal membrane as both monomers and higher-order oligomers that undergo liquid-liquid phase separation (LLPS) to form membrane microdomains essential for SNCA recognition and translocation into the lysosomal lumen. Recent biophysical studies demonstrate that LAMP2A's cytosolic tail contains an intrinsically disordered region capable of mediating homotypic LLPS, creating lipid-raft-like microdomains enriched in chaperone-HSC70. In A9 dopaminergic neurons (vulnerable), LAM
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
LAMP2 Phase Separation Protein Aggregation neurodegeneration
Convergent signals
LAMP2 recurs across 2 selected hypotheses with aligned directionality in phase separation, protein aggregation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 1/11
dimensions won
SNCA Oligomer Binding to LAMP2A Cytosoli
4/11
dimensions won
LAMP2A Liquid-Liquid Phase Separation De
Radar Chart — 10 Dimensions
Score Breakdown
Dimension SNCA Oligomer Binding to LAMP2 LAMP2A Liquid-Liquid Phase Sep Mechanistic 0.680 0.750 Evidence 0.620 0.680 Novelty 0.900 0.920 Feasibility 0.000 0.000 Impact 0.000 0.000 Druggability 0.000 0.000 Safety 0.000 0.000 Competition 0.000 0.000 Data 0.000 0.000 Reproducible 0.000 0.000 KG Connect 0.500 0.500
Evidence SNCA Oligomer Binding to LAMP2A Cytosolic Tail Prevents Tors No evidence citations yet
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi No evidence citations yet
Price History Overlay